Biochemist and protein crystallographer Dr. Oliver Daumke of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, has won the “Bayer Early Excellence in Science Award 2010” in the biology category. He will receive the prize worth EUR 10,000 for his contributions to the understanding of the structure and function of GTP-binding (G) proteins… Continue reading
Tag: new
New Functions For New Genes
Research at the Centre for Genomic Regulation (CRG) in Barcelona, Spain and the Wistar Institute in Philadelphia, USA has revealed a novel mechanism for the control of human genes. The work, published in Cell, present an anticipated mode of regulation of some processes such as differentiation and development or oncogenesis. Thanks to the new technological… Continue reading
New food-related methow who can tell if you have hepatic steatosis
A multidisciplinary research team from the Instituto Biodonostia made up by digestologists, epidemiologists and researchers of the Experimental Unit evaluated the use of a method so far employed in the food industry to improve the diagnosis of hepatic steatosis. Fatty liver is one of the most frequent liver diseases and it is promoted by obesity… Continue reading
A new therapeutic intervention for Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant digestive tumor with a very poor prognosis. Hypoxia-inducible transcription factor-1α (HIF-1α) is involved in malignant progression in many solid tumors, including PDAC, upregulation of HIF-1α accelerates PDAC progression, but the exact regulatory mechanisms of HIF-1αin PDAC has not been unequivocally addressed. Recently, an increasing number of studies… Continue reading
The way that the wrong genes are repressed
The mechanism by which ‘polycomb’ proteins critical for embyronic stem cell function and fate are targeted to DNA has been identified by UCL scientists. The discovery, which has implications for the fields of stem cell and tissue engineering, is detailed in research published in the journal Molecular Cell. A key feature of stem cells is… Continue reading
New experimental drug shrank the lung cancer’s tumor in 90% of patients
An extremely promising experimental drug, called crizotinib for lung cancer patients with a specific gene has shrunk tumors in 90% of patients in a clinical study within two months, researchers from Pfizer. Inc. said. With expectations of just a 10% response rate to this new medication – which would have been good news anyway –… Continue reading
Urologists with new researches at AUA’s 2010 meeting
Ihor S. Sawczuk, M.D., Co-Chief of the Division of Urologic Oncology at John Theurer Cancer Center at Hackensack University Medical Center, internationally recognized for his work in urologic oncology, was among physicians from the Cancer Center presenting research abstracts at the American Urological Association’s 2010 Annual Meeting. The American Urological Association (AUA) is committed to… Continue reading
New effective bipolar and schizophrenia drug
The FDA has approved a new drug called Saphris to treat schizophrenia and bipolar I disorder in adults. “Mental illnesses like schizophrenia and bipolar disorder can be devastating to patients and families, requiring lifelong treatment and therapy,” Thomas Laughren, MD, director of the division of psychiatry products in the FDA’s Center for Drug Evaluation and… Continue reading